These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10821720)

  • 1. 7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecine: a new heterocyclic system and a new lead compound for dopamine receptor antagonists.
    Witt T; Hock FJ; Lehmann J
    J Med Chem; 2000 May; 43(10):2079-81. PubMed ID: 10821720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine/serotonin receptor ligands. Part 15: Oxygenation of the benz-indolo-azecine LE 300 leads to novel subnanomolar dopamine D1/D5 antagonists.
    Enzensperger C; Kilian S; Ackermann M; Koch A; Kelch K; Lehmann J
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1399-402. PubMed ID: 17188870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and 5-HT2A antagonist activity of derivatives of the novel heterocycles indolo[3,2-d]pyrrolo[3,2-g]azecine and benzo[d]pyrrolo[3,2-g]azecine compared to the benz[d]indolo[2,3-g]azecine derivative LE 300.
    Rostom SA; Farghaly AM; Soliman FS; el-Semary MM; Elz S; Lehmann J
    Arch Pharm (Weinheim); 2001 Jul; 334(7):241-7. PubMed ID: 11512275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of the benz[d]indolo[2,3-g]azecine LE300, a novel type of a nanomolar dopamine receptor antagonist.
    Kassack MU; Höfgen B; Decker M; Eckstein N; Lehmann J
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):543-50. PubMed ID: 12444495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine/serotonin receptor ligands, part III [1]: synthesis and biological activities of 7, 7'-alkylene-bis-6, 7, 8, 9, 14, 15-hexahydro-5H-benz[d]indolo[2, 3-g]azecines -- application of the bivalent ligand approach to a novel type of dopamine receptor antagonist.
    Abadi AH; Lankow S; Hoefgen B; Decker M; Kassack MU; Lehmann J
    Arch Pharm (Weinheim); 2002 Aug; 335(8):367-73. PubMed ID: 12397620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel fused pyrrole heterocyclic ring systems as structure analogs of LE 300: Synthesis and pharmacological evaluation as serotonin 5-HT(2A), dopamine and histamine H(1) receptor ligands.
    Rostom SA
    Arch Pharm (Weinheim); 2010 Feb; 343(2):73-80. PubMed ID: 20108267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.
    Hoefgen B; Decker M; Mohr P; Schramm AM; Rostom SA; El-Subbagh H; Schweikert PM; Rudolf DR; Kassack MU; Lehmann J
    J Med Chem; 2006 Jan; 49(2):760-9. PubMed ID: 16420061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cis-1,2,3a,4,5,9b-hexahydro-3H-benz[e]indoles: synthesis and in vitro binding affinity at dopamine D1 and D2 receptors.
    Cruse SF; Lear J; Klein CL; Andersen PH; Dick RM; Crider AM
    J Pharm Sci; 1993 Mar; 82(3):334-9. PubMed ID: 8095545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor ligands. Part 18: (1) modification of the structural skeleton of indolobenzazecine-type dopamine receptor antagonists.
    Robaa D; Enzensperger C; Abul Azm Sel D; El Khawass el S; El Sayed O; Lehmann J
    J Med Chem; 2010 Mar; 53(6):2646-50. PubMed ID: 20180564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain: potential interaction with A2A and D2-like receptors.
    Leonard SK; Ferry-Leeper P; Mailman RB
    Brain Res; 2006 Oct; 1117(1):25-37. PubMed ID: 16962565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine/serotonin receptor ligands. Part IV [1]: synthesis and pharmacology of novel 3-benzazecines and 3-benzazonines as potential 5-HT2A and dopamine receptor ligands.
    El-Subbagh H; Wittig T; Decker M; Elz S; Nieger M; Lehmann J
    Arch Pharm (Weinheim); 2002 Nov; 335(9):443-8. PubMed ID: 12447918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine/serotonin receptor ligands. 13: Homologization of a benzindoloazecine-type dopamine receptor antagonist modulates the affinities for dopamine D(1)-D(5) receptors.
    Enzensperger C; Lehmann J
    J Med Chem; 2006 Oct; 49(21):6408-11. PubMed ID: 17034146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzazepines: structure-activity relationships between D1 receptor blockade and selected pharmacological effects.
    Iorio LC; Barnett A; Billard W; Gold EH
    Adv Exp Med Biol; 1986; 204():1-14. PubMed ID: 2947422
    [No Abstract]   [Full Text] [Related]  

  • 14. Atypical SCH23390 binding sites are present on bovine adrenal medullary membranes.
    Dahmer MK; Senogles SE
    Neurochem Res; 2000 Mar; 25(3):321-6. PubMed ID: 10761974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Link between dopamine D1 and D2 receptors in rat and human striatal tissues.
    Seeman P; Tallerico T
    Synapse; 2003 Mar; 47(4):250-4. PubMed ID: 12539197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ligand binding ability of dopamine D1 receptors synthesized using a wheat germ cell-free protein synthesis system with liposomes.
    Arimitsu E; Ogasawara T; Takeda H; Sawasaki T; Ikeda Y; Hiasa Y; Maeyama K
    Eur J Pharmacol; 2014 Dec; 745():117-22. PubMed ID: 25446930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
    Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
    Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chiral indolo[3,2-f][3]benzazecine-type dopamine receptor antagonists: synthesis and activity of racemic and enantiopure derivatives.
    Robaa D; Enzensperger C; Eldin Abulazm S; Hefnawy MM; El-Subbagh HI; Wani TA; Lehmann J
    J Med Chem; 2011 Oct; 54(20):7422-6. PubMed ID: 21888437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.